CORNELIUS (COloRectal CaNcEr in ELderly MultImorbide PopUlationS): a non-interventional observational study

CORNELIUS (COloRectal CaNcEr in ELderly MultImorbide PopUlationS): a non-interventional observational study - CORNELIUS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00011482

Enrollment

800

Registered

2016-12-15

Start date

2016-10-28

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C18

Interventions

Group 1: Efficacy and safety profile of oxaliplatin or axinotecan will be documented under routine practice conditions in patients where treatment with oxaliplatin or axinotecan is indicated. No furt

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Signed and dated consent is available - The treatment decision was made independently of a possible inclusion in the study - Patient is not at the same time a clinical trial participant - Patient is at least 18 years old.

Exclusion criteria

Exclusion criteria: According to contraindications and special warnings in the SPCs axinotecan 20 mg/ml and oxaliplatin.

Design outcomes

Primary

Measure	Time frame
Efficacy and tolerability of oxaliplatin or axinotecan in routine practice	—

Secondary

Measure	Time frame
Side effects which were not reported so far	—

Countries

Germany

Contacts

Public ContactAndreas Schuster

axios Pharma GmbH

info@axios-pharma.de+49 521 98 83 50

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026